A collaborative research program to integrate genomic and proteomic data for the identification of predictive biomarkers in bladder cancer

整合基因组和蛋白质组数据以鉴定膀胱癌预测生物标志物的合作研究计划

• 批准号: 182344
• 负责人: Zhang Zhaolei
• 金额: $ 7.29万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2009
• 资助国家: 加拿大
• 起止时间: 2009-03-01 至 2010-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=182344&lang=en
• 关键词: Biomarkers; Bionformatics; Bladder Cancer; Cancer Diagnostics; Genomics; Proteomics

Bladder cancer is one of the most prevalent and costly cancer types in Canada, with about 6600 new cases and 1750 deaths from this disease each year. Early diagnosis and improved management of bladder cancer would be improved by the availability of biomar

膀胱癌是加拿大最常见和最昂贵的癌症类型之一，每年约有 6600 例新发病例和 1750 人死于该疾病。生物标记物的可用性将改善膀胱癌的早期诊断和改善治疗